REXAHN PHARMACEUTICALS, INC. 4
4 · REXAHN PHARMACEUTICALS, INC. · Filed Sep 5, 2014
Insider Transaction Report
Form 4
Suzdak Peter David
Chief Executive Officer
Transactions
- Award
Stock Option (right to purchase)
2014-09-04+1,000,000→ 1,000,000 totalExercise: $0.83Exp: 2024-09-04→ Common Stock (1,000,000 underlying)
Footnotes (1)
- [F1]Options will vest and be exercisable based on the following schedule: 250,000 on September 4, 2015, 250,000 on September 4, 2016, 250,000 on September 4, 2017, and 250,000 on September 4, 2018.